|
1
|
Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
|
Cancer Res
|
2010
|
1.91
|
|
2
|
p53 negatively regulates expression of FoxM1.
|
Cell Cycle
|
2009
|
1.49
|
|
3
|
Design, synthesis, and studies of small molecule STAT3 inhibitors.
|
Bioorg Med Chem Lett
|
2007
|
1.18
|
|
4
|
Conformationally restricted analogs of Combretastatin A-4 derived from SU5416.
|
Bioorg Med Chem Lett
|
2005
|
1.02
|
|
5
|
New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
|
Cancer Sci
|
2009
|
1.01
|
|
6
|
Structure-activity relationship studies of curcumin analogues.
|
Bioorg Med Chem Lett
|
2009
|
0.97
|
|
7
|
A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
|
Mol Cancer Ther
|
2006
|
0.91
|
|
8
|
ARC synergizes with ABT-737 to induce apoptosis in human cancer cells.
|
Mol Cancer Ther
|
2010
|
0.86
|
|
9
|
Synthesis of 4'-hydroxy-3'-piperidinomethylchalcone derivatives and their cytotoxicity against PC-3 cell lines.
|
Arch Pharm (Weinheim)
|
2007
|
0.85
|
|
10
|
Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
|
Am J Pathol
|
2013
|
0.84
|
|
11
|
Inhibitors of NF-kappaB derived from thalidomide.
|
Bioorg Med Chem Lett
|
2007
|
0.83
|
|
12
|
Structure-activity relationships studies of the anti-angiogenic activities of linomide.
|
Bioorg Med Chem Lett
|
2003
|
0.81
|
|
13
|
Evaluation of the cytotoxicity of some mono-mannich bases and their corresponding azine derivatives against androgen-independent prostate cancer cells.
|
Arzneimittelforschung
|
2006
|
0.80
|
|
14
|
Synthesis and cytotoxicity of novel 3-aryl-1-(3'-dibenzylaminomethyl-4'-hydroxyphenyl)-propenones and related compounds.
|
Chem Pharm Bull (Tokyo)
|
2008
|
0.79
|
|
15
|
Proteasome inhibitors suppress the protein expression of mutant p53.
|
Cell Cycle
|
2014
|
0.76
|
|
16
|
Biological activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols on PC-3 cells and DNA topoisomerase I enzyme.
|
Z Naturforsch C
|
2011
|
0.75
|
|
17
|
Design, synthesis and biological studies of novel tubulin inhibitors.
|
Bioorg Med Chem Lett
|
2013
|
0.75
|